These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 30938285)
21. Tolerance of benznidazole in a United States Chagas Disease clinic. Miller DA; Hernandez S; Rodriguez De Armas L; Eells SJ; Traina MM; Miller LG; Meymandi SK Clin Infect Dis; 2015 Apr; 60(8):1237-40. PubMed ID: 25601454 [TBL] [Abstract][Full Text] [Related]
22. Adverse systemic reaction to benznidazole. Coronel MV; Frutos LO; Muñoz EC; Valle DK; Rojas DH Rev Soc Bras Med Trop; 2017; 50(1):145-147. PubMed ID: 28327820 [TBL] [Abstract][Full Text] [Related]
23. Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial. Villar JC; Herrera VM; Pérez Carreño JG; Váquiro Herrera E; Castellanos Domínguez YZ; Vásquez SM; Cucunubá ZM; Prado NG; Hernández Y Trials; 2019 Jul; 20(1):431. PubMed ID: 31307503 [TBL] [Abstract][Full Text] [Related]
25. Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil. Gontijo MKCL; Arruda HMBDS; Noronha EF; Toledo MI Rev Soc Bras Med Trop; 2020; 53():e20190150. PubMed ID: 31994658 [TBL] [Abstract][Full Text] [Related]
26. An update on benznidazole for the treatment of patients with Chagas disease. Thakare R; Dasgupta A; Chopra S Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of Chagas disease with benznidazole and thioctic acid]. Roldán EJ Medicina (B Aires); 2005; 65(1):85-6; author reply 86-7. PubMed ID: 15830800 [No Abstract] [Full Text] [Related]
28. Should benznidazole be used in chronic Chagas' disease? Bestetti RB Lancet; 1997 Mar; 349(9052):653. PubMed ID: 9057760 [No Abstract] [Full Text] [Related]
29. A clinical adverse drug reaction prediction model for patients with chagas disease treated with benznidazole. Sperandio da Silva GM; Mediano MF; Alvarenga Americano do Brasil PE; da Costa Chambela M; da Silva JA; de Sousa AS; Xavier SS; Rodrigues da Costa A; Magalhães Saraiva R; Hasslocher-Moreno AM Antimicrob Agents Chemother; 2014 Nov; 58(11):6371-7. PubMed ID: 25114135 [TBL] [Abstract][Full Text] [Related]
30. Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease. Pinazo MJ; Guerrero L; Posada E; Rodríguez E; Soy D; Gascon J Antimicrob Agents Chemother; 2013 Jan; 57(1):390-5. PubMed ID: 23114763 [TBL] [Abstract][Full Text] [Related]
31. Experimental combination therapy using low doses of benznidazole and allopurinol in mouse models of Trypanosoma cruzi chronic infection. Rial MS; Scalise ML; López Alarcón M; Esteva MI; Búa J; Benatar AF; Prado NG; Riarte AR; Fichera LE Parasitology; 2019 Mar; 146(3):305-313. PubMed ID: 30301480 [TBL] [Abstract][Full Text] [Related]
32. Benznidazole therapy for Chagas disease in asymptomatic Trypanosoma cruzi -seropositive former blood donors: evaluation of the efficacy of different treatment regimens. Antunes AP; Ribeiro AL; Sabino EC; Silveira MF; Oliveira CD; Botelho AC Rev Soc Bras Med Trop; 2016; 49(6):713-720. PubMed ID: 28001218 [TBL] [Abstract][Full Text] [Related]
33. Adverse events after the use of benznidazole in infants and children with Chagas disease. Altcheh J; Moscatelli G; Moroni S; Garcia-Bournissen F; Freilij H Pediatrics; 2011 Jan; 127(1):e212-8. PubMed ID: 21173000 [TBL] [Abstract][Full Text] [Related]
34. Low-dose of benznidazole promotes therapeutic cure in experimental chronic Chagas' disease with absence of parasitism in blood, heart and colon. Perin L; Fonseca KDS; de Carvalho TV; Carvalho LM; Madeira JV; Medeiros LDF; Molina I; Correa-Oliveira R; Carneiro CM; Vieira PMA Exp Parasitol; 2020 Mar; 210():107834. PubMed ID: 31978394 [TBL] [Abstract][Full Text] [Related]
36. Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment. Pérez-Molina JA; Sojo-Dorado J; Norman F; Monge-Maillo B; Díaz-Menéndez M; Albajar-Viñas P; López-Vélez R Acta Trop; 2013 Aug; 127(2):101-4. PubMed ID: 23583863 [TBL] [Abstract][Full Text] [Related]
38. Current and developing therapeutic agents in the treatment of Chagas disease. Apt W Drug Des Devel Ther; 2010 Sep; 4():243-53. PubMed ID: 20957215 [TBL] [Abstract][Full Text] [Related]